Merck is a global leader in providing technologies, research solutions and therapeutics to aid in the fight against the COVID-19 pandemic. Merck's life science solutions and services are supporting pharmaceutical and biotech companies in the development of COVID-19 vaccines and treatments, including more than 50 potential COVID-19 vaccines; over 35 solutions for testing; and more than 20 monoclonal antibodies, plasma products, and antiviral drugs. Browse through the list of solutions below that focus on Immunoassays for COVID-19 Research, as well as SARS-CoV-2 Detection in Wastewater Surveillance.

SOLUTIONS FOR COVID-19 RESEARCH

FEATURED TOPICS

Immunoassays for

COVID-19 Research

Surveillance of

SARS-CoV-2 in Wastewater

Immunoassays for COVID-19 Research

Providing the specificity, biological dynamic ranges, and sensitivity that you require, our versatile ELISAs, ultrasensitive SMC™ assays, and MILLIPLEX® multiplex assays using Luminex® xMAP® technology deliver consistent performance, lot after lot.

Wastewater SARS-CoV-2 Research Solutions

For the past 16 months, scientists have engaged in research using wastewater tests as an additional tool to track the spread of the coronavirus. Testing SARS-CoV-2 viral loads in wastewater has recently emerged as a method of tracking the prevalence of the virus and an early-warning tool for predicting outbreaks in the future. Browse through the studies listed below, which highlight the use of Merck's filtration devices in the detection SARS-CoV-2 in wastewater.

ASK US ANYTHING


ADDRESS

Gulf Scientific Corporation

PO Box 17010

Street N500 Jebel Ali Freezone (JAFZA 4)

Dubai, United Arab Emirates

OPENING HOURS

08:00 - 17:00

CONTACT

Tel: +971 4 881 5270

Fax: +971 4 881 6778